SUBSCRIBE
MENU
HOME
ABOUT US
Mission and Vision
Management Team
Board of Directors
Scientific Advisory Board
MYHEART™ PRODUCTS
Overview
Why MyHeart™?
Human Ventricular Cardiomyocytes
Cardiac Anisotropic Sheet
Cardiac Tissue Strip
Cardiac Organoid Chamber
SERVICES
Overview
Screening & Phenotyping Services
Consultation
RESOURCES
Downloads
Online References
Media Kit
INVESTORS
Overview
Stock Information
Press Releases
Financial Information
Corporate Governance
FAQs
Investor Contact
NEWS
Press Releases
Company Updates
Media Coverage
CONTACT
PRESS RELEASES
08
Feb
2019
Novoheart Grants Stock Options and RSUs
07
Jan
2019
Novoheart Provides Corporate Update
23
Nov
2018
Novoheart Holdings Inc. Reports First Quarter 2019 Financial Results
31
Oct
2018
Novoheart to Generate USD $1.7m From Strategic Partnership to Build Good Manufacturing Practice Facility to Create Clinical-Grade Human Stem Cell Libraries
24
Sep
2018
Novoheart Recruits Notable Pharma Industry Executive, Bernard Fermini, Ph.D. as Chief R&D Officer
1
2
3
>
Last ›
Subscribe To Our Newsletter
Fill out the following to subscribe and start receiving updates from us!
Subscribe Now
No Thanks
